adding glp-1 to insulin Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature GLP-1 receptor agonists and type

An analysis of the FDA Adverse Event Reporting System (collecting worldwide adverse events) identified an increased reporting odds ratio for alopecia with semaglutide and tirzepatide, while no significant increase was observed for liraglutide, dulaglutide, exenatide, or lixisenatide [81]

Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients With Cushings Disease During Active Disease and 1 Year After Disease Remission

Its mild laxative effect can help relieve intestinal congestion and promote the elimination of metabolic waste

Overall, antipsychotic drugs were significantly more effective than mood stabilizers